Education | cannabiscouncil

Education and Resources

The Council is currently working with several groups, such as the PSA and Medical Cannabis Research Australia, to provide education for health professionals - more coming soon

FACT SHEETS

MCC Fact Sheet - Patient Access

MCC Fact Sheet - Importation

MCC Fact Sheet - Cultivation & Manufacturing

TGA Fact Sheet - Access to Medicinal Cannabis

TGA - Patient Information

TGA - Multiple Sclerosis

TGA - Chronic Pain

TGA - Neasea and Vomiting

TGA - Palliative Care

TGA - Epilepsy

NSW Fact Sheet - Compassionate Access Scheme

VIC Fact Sheet - Information for Patients and Carers

VIC Fact Sheet - Information for Medical Professionals

VIC Fact Sheet - Medicinal Cannabis Industry Development

SA Fact Sheet - Approvals to prescribe medicinal cannabis in South Australia

SA Fact Sheet - Medicinal Cannabis Industry in South Australia

TAS Fact Sheet - Access Information for Patients

TAS Fact Sheet - Information for Health Professionals

WA Fact Sheet - Quick Guide for Health Professionals

WA Fact Sheet - Prescribing Approvals Process

PEER-REVIEWED PAPERS

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, The National Academies of Sciences, Engineering and Medicine

Epilepsy - Randomised Controlled Trials

Devinksy et al. (2017), Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome, New England Journal of Medicine

Cunha et al. (1980), Chronic administration of cannabidiol to healthy volunteers and epileptic patients, Pharmacology

Epilepsy - Other Studies

Devinksy et al. (2016), Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial, Lancet Neurology

Hess et al. (2016), Cannabidiol as a new treatment for drug‐resistant epilepsy in tuberous sclerosis complex, Epilepsia

Tzadok et al. (2016), CBD-enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience, Seizure

MS - Randomised Controlled Trials

Zajicek et al. (2003), Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial, The Lancet

Turcotte et al. (2015), Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial, Pain Medicine

Langford et al. (2013), A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis, Journal of Neurology

Zajicek et al. (2012), Multiple sclerosis and extract of cannabis: results of the MUSEC trial, Journal of Neurology, Neurosurgery, and Psychiatry

Kavia et al. (2010), Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis, Multiple Sclerosis

Collin et al. (2007), Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis, European Journal of Neurology

Rog et al. (2005), Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis, Neurology

Wade et al. (2004), Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients, Multiple Sclerosis

Nausea and Vomiting - Randomised Controlled Trials

Meiri et al. (2007), Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting, Current Medical Research and Opinion

Strasser et al. (2006), Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-in-Cachexia-Study-Group, Journal of Clinical Oncology

Abrams et al. (2003), Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial, Annals of Internal Medicine

Palliation - Randomised Controlled Trials

Portenoy et al. (2012), Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial, Journal of Pain

COMMONWEALTH

Narcotic Drugs Amendment Act 2016

Therapeutic Goods and Other Legislation Amendment (Narcotic Drugs) Regulation 2016

Authorised Prescriber Guidelines

Special Access Scheme Guidelines

ODC Presentation - Regulating Cannabis (July 2017)

TGA Presentation - Legislative Framework

For more information, visit the ODC or the TGA website.

NEW SOUTH WALES

Poisons and Therapeutic Goods Amendment (Designated Non-ARTG Products) Regulation 2016

For more information, visit NSW Health, NSW Health Pharmaceutical Services or the Centre for Medicinal Cannabis Research and Innovation.

QUEENSLAND

Public Health (Medicinal Cannabis) Act 2016

Public Health (Medicinal Cannabis) Regulation 2017

Clinical Guidance for the use of medicinal cannabis products in Queensland

Medicinal cannabis access and use in Queensland

For more information, visit QLD Health.

SOUTH AUSTRALIA

For information on medical cannabis in South Australia, visit SA Health or the Office of Industrial Hemp and Medical Cannabis.

TASMANIA

For information on medical cannabis in Tasmania, see the links under the Factsheet section of this page, or visit Tasmanian Department of Health and Human Services.